Literature DB >> 21944878

S100-B protein as a screening tool for the early assessment of minor head injury.

Drissa Zongo1, Régis Ribéreau-Gayon, Françoise Masson, Magali Laborey, Benjamin Contrand, Louis Rachid Salmi, Danièle Montaudon, Jean Louis Beaudeux, Antoine Meurin, Vincent Dousset, Hugues Loiseau, Emmanuel Lagarde.   

Abstract

STUDY
OBJECTIVE: A computed tomography (CT) scan has high sensitivity in detecting intracranial injury in patients with minor head injury but is costly, exposes patients to high radiation doses, and reveals clinically relevant lesions in less than 10% of cases. We evaluate S100-B protein measurement as a screening tool in a large population of patients with minor head injury.
METHODS: We conducted a prospective observational study in the emergency department of a teaching hospital (Bordeaux, France). Patients with minor head injury (2,128) were consecutively included from December 2007 to February 2009. CT scans and plasma S100-B levels were compared for 1,560 patients. The main outcome was to evaluate the diagnostic value of the S100-B test, focusing on the negative predictive value and the negative likelihood ratio.
RESULTS: CT scan revealed intracranial lesions in 111 (7%) participants, and their median S100-B protein plasma level was 0.46 μg/L (interquartile range [IQR] 0.27 to 0.72) versus 0.22 μg/L (IQR 0.14 to 0.36) in the other 1,449 patients. With a cutoff of 0.12 μg/L, traumatic brain injuries on CT were identified with a sensitivity of 99.1% (95% confidence interval [CI] 95.0% to 100%), a specificity of 19.7% (95% CI 17.7% to 21.9%), a negative predictive value of 99.7% (95% CI 98.1% to 100%), a positive likelihood ratio of 1.24 (95% CI 1.20 to 1.28), and a negative likelihood ratio of 0.04 (95% CI 0.006 to 0.32).
CONCLUSION: Measurement of plasma S100-B on admission of patients with minor head injury is a promising screening tool that may be of help to support the clinician's decision not to perform CT imaging in certain cases of low-risk head injury.
Copyright © 2011 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944878     DOI: 10.1016/j.annemergmed.2011.07.027

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  35 in total

1.  S100B blood levels and childhood trauma in adolescent inpatients.

Authors:  Tatiana Falcone; Damir Janigro; Rachel Lovell; Barry Simon; Charles A Brown; Mariela Herrera; Aye Mu Myint; Amit Anand
Journal:  J Psychiatr Res       Date:  2014-12-25       Impact factor: 4.791

Review 2.  The current state of biomarkers of mild traumatic brain injury.

Authors:  Han Jun Kim; Jack W Tsao; Ansley Grimes Stanfill
Journal:  JCI Insight       Date:  2018-01-11

Review 3.  A systematic review of the biomarker S100B: implications for sport-related concussion management.

Authors:  Stefanie Schulte; Leslie W Podlog; J Jordan Hamson-Utley; Frederick G Strathmann; Heiko K Strüder
Journal:  J Athl Train       Date:  2014 Nov-Dec       Impact factor: 2.860

4.  Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Authors:  Robert D Welch; Morgan Ellis; Lawrence M Lewis; Syed I Ayaz; Valerie H Mika; Scott Millis; Linda Papa
Journal:  J Neurotrauma       Date:  2017-02-27       Impact factor: 5.269

5.  Range of S-100β levels during functional endoscopic sinus surgery with moderately controlled hypotension.

Authors:  Youngsuk Kwon; Ji Su Jang; Sung Mi Hwang; Jae Jun Lee; Jun Ho Lee; Sungmin Joo; In-Gon Lee; Sung Jun Hong
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-29       Impact factor: 2.503

Review 6.  S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Michael Amoo; Jack Henry; Philip J O'Halloran; Paul Brennan; Mohammed Ben Husien; Matthew Campbell; John Caird; Mohsen Javadpour; Gerard F Curley
Journal:  Neurosurg Rev       Date:  2021-10-28       Impact factor: 3.042

7.  Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.

Authors:  Jeffrey J Bazarian; Brian J Blyth; Hua He; Sohug Mookerjee; Courtney Jones; Karin Kiechle; Ryan Moynihan; Susan M Wojcik; William D Grant; LaLainia M Secreti; Wayne Triner; Ronald Moscati; August Leinhart; George L Ellis; Jawwad Khan
Journal:  J Neurotrauma       Date:  2013-08-24       Impact factor: 5.269

8.  Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update.

Authors:  Johan Undén; Tor Ingebrigtsen; Bertil Romner
Journal:  BMC Med       Date:  2013-02-25       Impact factor: 8.775

9.  Consequences of repeated blood-brain barrier disruption in football players.

Authors:  Nicola Marchi; Jeffrey J Bazarian; Vikram Puvenna; Mattia Janigro; Chaitali Ghosh; Jianhui Zhong; Tong Zhu; Eric Blackman; Desiree Stewart; Jasmina Ellis; Robert Butler; Damir Janigro
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Clinical validation of S100B use in management of mild head injury.

Authors:  Olga Calcagnile; Linda Undén; Johan Undén
Journal:  BMC Emerg Med       Date:  2012-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.